100 related articles for article (PubMed ID: 20705371)
1. Antihypertensive and antiarrhythmic properties of a para-hydroxy[bis(ortho-morpholinylmethyl)]phenyl-1,4-DHP compound: comparison with other compounds of the same kind and relationship with logP values.
Abrego VH; Martínez-Pérez B; Torres LA; Angeles E; Martínez L; Marroquín-Pascual JL; Moya-Hernández R; Amaro-Recillas HA; Rueda-Jackson JC; Rodríguez-Barrientos D; Rojas-Hernández A
Eur J Med Chem; 2010 Oct; 45(10):4622-30. PubMed ID: 20705371
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and pharmacological evaluation of new 1-[3-(4-arylpiperazin-1-yl)-2-hydroxy-propyl]-3,3-diphenylpyrrolidin-2-one derivatives with antiarrhythmic, antihypertensive, and alpha-adrenolytic activity.
Kulig K; Sapa J; Nowaczyk A; Filipek B; Malawska B
Eur J Med Chem; 2009 Oct; 44(10):3994-4003. PubMed ID: 19447527
[TBL] [Abstract][Full Text] [Related]
3. Deprotonation mechanism of new antihypertensive piperidinylmethylphenols: a combined experimental and theoretical study.
Islas-Martínez JM; Rodríguez-Barrientos D; Galano A; Angeles E; Torres LA; Olvera F; Ramírez-Silva MT; Rojas-Hernández A
J Phys Chem B; 2009 Aug; 113(34):11765-74. PubMed ID: 19653668
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and pharmacological screening of novel antihypertensive agents using hybrid approach.
Bhandari SV; Bothara KG; Patil AA; Chitre TS; Sarkate AP; Gore ST; Dangre SC; Khachane CV
Bioorg Med Chem; 2009 Jan; 17(1):390-400. PubMed ID: 19036593
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and evaluation of in vivo activity of diphenylhydantoin basic derivatives.
Dylag T; Zygmunt M; Maciag D; Handzlik J; Bednarski M; Filipek B; Kieć-Kononowicz K
Eur J Med Chem; 2004 Dec; 39(12):1013-27. PubMed ID: 15571863
[TBL] [Abstract][Full Text] [Related]
6. Comparative QSAR studies of two series of 1,4-dihydropyridines as slow calcium channel blockers.
Wikel JH; Bemis KG; Kurz K; Denney ML; Main BW; Moore RA; Smith T; Shingleton L; Holland DR
Drug Des Discov; 1994 Jan; 11(1):1-14. PubMed ID: 8068815
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and pharmacological evaluation of new 1-[3-(4-arylpiperazin-1-yl)-2-hydroxypropyl]-pyrrolidin-2-one derivatives with anti-arrhythmic, hypotensive, and alpha-adrenolytic activity.
Kulig K; Sapa J; Maciag D; Filipek B; Malawska B
Arch Pharm (Weinheim); 2007 Sep; 340(9):466-75. PubMed ID: 17806129
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and antihypertensive effects of new methylthiomorpholinphenol derivatives.
Velázquez AM; Martínez L; Abrego V; Balboa MA; Torres LA; Camacho B; Díaz-Barriga S; Romero A; López-Castañares R; Angeles E
Eur J Med Chem; 2008 Mar; 43(3):486-500. PubMed ID: 17582658
[TBL] [Abstract][Full Text] [Related]
9. Antiarrhythmic and hypotensive activities of 1-[2-hydroxy-3-(4-phenyl-1-piperazinyl)propyl]-pyrrolidin-2-one (MG-1(R,S)) and its enantiomers.
Sapa J; Filipek B; Nowiński L
Pharmacol Rep; 2011; 63(2):455-63. PubMed ID: 21602601
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and antihypertensive activities of new 1,4-dihydropyridine derivatives containing nitrooxyalkylester moieties at the 3- and 5-positions.
Ogawa T; Nakazato A; Tsuchida K; Hatayama K
Chem Pharm Bull (Tokyo); 1993 Jun; 41(6):1049-54. PubMed ID: 8370105
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and pharmacological evaluation of new 1-[3-(4-phenylpiperazin-1-yl)-propyl]- and 1-[3-(4-phenylpiperidine)-propyl]- 3-aryl-3-alkyl-pyrrolidin-2-one derivatives with antiarrhythmic and antihypertensive activity.
Kulig K; Sapa J; Nowaczyk A; Filipek B; Malawska B
Acta Pol Pharm; 2009; 66(6):649-62. PubMed ID: 20050529
[TBL] [Abstract][Full Text] [Related]
12. Acute antihypertensive effects of the new generation calcium antagonist 3-pyridine carboxylic acid 5-[(cyclopropylamino)-carbonyl]-1,4-dihydro-2,6-dimethyl-4-(2-nitrophen yl) octyl ester on conscious spontaneously hypertensive rats and renal hypertensive rats.
Hojo M; Tanaka Y; Katayama O; Teramoto N
Arzneimittelforschung; 1993 Aug; 43(8):847-51. PubMed ID: 8216440
[TBL] [Abstract][Full Text] [Related]
13. Preliminary evaluation of pharmacological properties of some xanthone derivatives.
Marona H; Szkaradek N; Rapacz A; Filipek B; Dybała M; Siwek A; Cegła M; Szneler E
Bioorg Med Chem; 2009 Feb; 17(3):1345-52. PubMed ID: 19131251
[TBL] [Abstract][Full Text] [Related]
14. 3-(Arylamino)-6,7-dihydro-6-methylpyrano[4,3-c]pyrazol-4(1H or 2H)-ones with antipyretic, analgesic, antiarrhythmic, hypotensive and other activities.
Bruno O; Ranise A; Schenone S; Bondavalli F; D'amico M; Falciani M; Berrino L; Rossi F
Farmaco; 1993 Dec; 48(12):1697-708. PubMed ID: 8135993
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular activity of the chiral xanthone derivatives.
Szkaradek N; Rapacz A; Pytka K; Filipek B; Żelaszczyk D; Szafrański P; Słoczyńska K; Marona H
Bioorg Med Chem; 2015 Oct; 23(20):6714-24. PubMed ID: 26386822
[TBL] [Abstract][Full Text] [Related]
16. Antiarrhythmic and antihypertensive activity of some xanthone derivatives.
Marona H; Librowski T; Cegła M; Erdoğan C; Sahin NO
Acta Pol Pharm; 2008; 65(3):383-90. PubMed ID: 18646559
[TBL] [Abstract][Full Text] [Related]
17. Antihypertensive effects of a new dihydropyridine calcium antagonist.
Kimura Y; Fukui H; Tanaka M; Okamoto M; Morino A; Miura A; Kimura K; Enomoto H
Arzneimittelforschung; 1986 Sep; 36(9):1329-35. PubMed ID: 3790182
[TBL] [Abstract][Full Text] [Related]
18. [Antiarrhythmic properties of afobazole and other 2-mercaptobensimidazole derivatives].
Turilova AI; Mozhaeva TIa
Eksp Klin Farmakol; 2010 May; 73(5):8-11. PubMed ID: 20597362
[TBL] [Abstract][Full Text] [Related]
19. Structure-activity study of antihypertensive 1,4-dihydropyridine derivatives having nitrooxyalkyl moieties at the 3 and 5 positions.
Kawashima Y; Ogawa T; Kato M; Nakazato A; Tsuchida K; Hatayama K; Hirono S; Moriguchi I
Chem Pharm Bull (Tokyo); 1993 Jun; 41(6):1060-5. PubMed ID: 8370106
[TBL] [Abstract][Full Text] [Related]
20. Antihypertensive effects of MPC-1304, a novel calcium antagonist, in experimental hypertensive rats and dogs.
Kanda A; Haruno A; Miyake H; Nagasaka M
J Cardiovasc Pharmacol; 1992; 20(5):723-30. PubMed ID: 1280733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
